Effects on bone formation in ovariectomized rats after implantation of tooth ash and plaster of Paris mixture.
OBJECTIVE
Our goal was to report on tooth ash and plaster of Paris mixture in bone defects in an ovariectomized rat osteoporosis model.


METHODS
Sixty rats were randomly assigned to 4 groups and each group was further divided into 3 subgroups: 4, 8, and 16 weeks after implantation. The defect was filled with different grafting conditions as follows: group 1, ovariectomy and nongraft group; group 2, ovariectomy and tooth ash-plaster graft group; group 3, nonovariectomy and nongraft group; and group 4, nonovariectomy and tooth ash-plaster graft group. Histologic sections and histomorphometric analysis of defects were obtained 4, 8, and 16 weeks after surgery.


RESULTS
For the 4-week ovariectomy group, there was significantly greater bone formation in tooth ash-plaster group compared with the nongraft group. In the nonovariectomy group, the tooth ash-plaster group also showed better bone formation than the nongraft group. However, there was no statistical significance. In both the ovariectomy and nonovariectomy groups, a significant increase in bone formation was observed according to the elapse of time. The nonovariectomy group showed increased new bone formation compared with the ovariectomy group, with the tooth ash-plaster group showing statistical significance in each subgroup (P =.048).


CONCLUSIONS
Ovariectomy acts as a negative factor in new bone formation. For a critical size bony defect, the tooth ash-plaster treatment of the osseous defect produces more stable, effective, and rapid new bone formation.
Kim
So-Young
SY
Oral Biology Research Institute, College of Dentistry, Chosun University, Gwangju, Korea.
Kim
Su-Gwan
SG
Lim
Sung-Chul
SC
Bae
Chun-Sik
CS
D000818:Animals; D018786:Bone Substitutes / Q000627:therapeutic use*; D002133:Calcium Sulfate / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005260:Female; D007091:Image Processing, Computer-Assisted; D008903:Minerals / Q000627:therapeutic use*; D010012:Osteogenesis / Q000502:physiology*; D010024:Osteoporosis / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012886:Skull / Q000473:pathology / Q000601:surgery*; D018709:Statistics, Nonparametric; D013997:Time Factors; D014070:Tooth / Q000737:chemistry*
D018786:Bone Substitutes; D008903:Minerals; D002133:Calcium Sulfate